3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Brain Neoplasms
3
Pancreatic Neoplasms
2
Breast Neoplasms
2
Warts
1
Surgical Wound
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Diseases
1
Sarcoma
1
Radiodermatitis
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroinflammatory Diseases
1
Melanoma
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Limited Stage Small Cell Lung Cancer
1
Hypoxia
1
Hemorrhage
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Atrial Fibrillation
1
Interventions
venetoclax
7
ibrutinib
7
Rituximab
6
Mycophenolic Acid
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Cyclosporins
2
Calcium Dobesilate
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
ixazomib
1
fludarabine
1
Transplantation
1
Specimen Handling
1
Rifaximin
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Sodium Chloride
×
90 days
×
Clear all
No trials found.